Cemiplimab: a new option for the treatment of non-small-cell lung cancer.

Future Oncol

Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, 94800, France.

Published: July 2021

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2021-0343DOI Listing

Publication Analysis

Top Keywords

cemiplimab option
4
option treatment
4
treatment non-small-cell
4
non-small-cell lung
4
lung cancer
4
cemiplimab
1
treatment
1
non-small-cell
1
lung
1
cancer
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!